ModeX doses first patients in trial of next-gen T-cell engager for aggressive B-cell lymphoma
The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack
The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack
Growth was broad-based across segments
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
Three-day programme focuses on advanced socket design, myoelectric technology and clinical skill development
Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages
Pharma giant targets new standards of care
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
The national platform brought together healthcare professionals, patient advocates, and stakeholders
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
Subscribe To Our Newsletter & Stay Updated